This compound is a phosphorylated, methylated guanosine derivative used as a pharmaceutical intermediate for RNA modification research. It features a methylated purine base and a phosphate group on the ribose sugar, with a net neutral charge.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-4-hydroxy-3-methoxyoxolan-2-yl]methyl phosphono phosphate;N,N-diethylethanamine
pharmaceutical intermediate
N(1)-methylpseudouridine 5'-monophosphate
pharmaceutical intermediate
1-Benzylpiperidin-4-one oxime
pharmaceutical intermediate
Paclitaxel side chain acid
pharmaceutical intermediate
1-(5-Chloropyridin-2-yl)ethanone
pharmaceutical intermediate
2,4-Dihydroxybenzaldehyde
pharmaceutical intermediate
7-methylguanosine 5'-diphosphate(1+)
pharmaceutical intermediate
[(2R,3R,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3-hydroxy-4-methoxyoxolan-2-yl]methyl hydrogen phosphate
FHSYAAQTDTXBME-IOSLPCCCSA-N
CN1C=[N+](C2=C1C(=O)NC(=N2)N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)[O-])O)OC
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.